DBV Technologies SA

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022

20 Jul 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI 2022 Congress

28 Jun 2022 18:15:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York

16 Jun 2022 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Private Placement Financing of $194 Million

09 Jun 2022 02:55:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers

07 Jun 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022

17 May 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting

12 May 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM)

04 May 2022 19:30:00 By Nasdaq GlobeNewswire

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

02 May 2022 17:00:24 By Nasdaq GlobeNewswire

DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results

02 May 2022 16:00:00 By Nasdaq GlobeNewswire

DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments

25 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

Ordinary and Extraordinary General Meeting of May 12, 2022

21 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022

14 Apr 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference

14 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022

11 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document

09 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates

03 Mar 2022 16:15:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022

24 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2022 Congress

22 Feb 2022 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

14 Feb 2022 16:30:00 By Nasdaq GlobeNewswire